Cargando…
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
BACKGROUND: NSCLC exhibits considerable heterogeneity in its sensitivity to chemotherapy and similar heterogeneity is noted in vitro in a variety of model systems. This study has tested the hypothesis that the molecular basis of the observed in vitro chemosensitivity of NSCLC lies within the known r...
Autores principales: | Glaysher, Sharon, Yiannakis, Dennis, Gabriel, Francis G, Johnson, Penny, Polak, Marta E, Knight, Louise A, Goldthorpe, Zoe, Peregrin, Katharine, Gyi, Mya, Modi, Paul, Rahamim, Joe, Smith, Mark E, Amer, Khalid, Addis, Bruce, Poole, Matthew, Narayanan, Ajit, Gulliford, Tim J, Andreotti, Peter E, Cree, Ian A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739227/ https://www.ncbi.nlm.nih.gov/pubmed/19712441 http://dx.doi.org/10.1186/1471-2407-9-300 |
Ejemplares similares
-
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
por: Glaysher, S, et al.
Publicado: (2010) -
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
por: Feng, Jian, et al.
Publicado: (2014) -
Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy
por: Sun, Wei, et al.
Publicado: (2017) -
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay
por: Knight, Louise A, et al.
Publicado: (2009) -
Inhibition of lncRNA PART1 Chemosensitizes Wild Type but Not KRAS Mutant NSCLC Cells
por: Chen, Shu-Chen, et al.
Publicado: (2020)